Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2008-03-04
2008-03-04
Davis, Brian (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C564S316000, C564S336000, C564S347000, C514S648000, C514S649000, C514S651000, C514S654000
Reexamination Certificate
active
11155345
ABSTRACT:
Thyronamine derivatives and analogs, methods of using such compounds, and pharmaceutical compositions containing them are disclosed. Methods of preparing such compounds are also disclosed.
REFERENCES:
patent: 11-302235 (1999-11-01), None
patent: WO 90/14334 (1990-11-01), None
patent: WO 98/27972 (1998-07-01), None
patent: WO 00/72811 (2000-12-01), None
patent: WO 01/56989 (2001-08-01), None
patent: WO 02/060375 (2002-08-01), None
patent: WO 03/002078 (2003-01-01), None
patent: WO 03/106380 (2003-12-01), None
patent: WO 2004/020415 (2004-03-01), None
Biondi, B., et al., “Effects of Subclinical Thyroid Dysfunction on the Heart”,Ann Intern Med., 137: 904-914, 2002.
Boissier, J.R., et al., “Differential Inotropic-Chronotropic Action of Thyronamine”,Eur. J. Pharmacol. 22: 141-149, 1973.
Borowsky, B., et al., “Trace amines: Identification of a family of mammalian G protein-coupled receptors”,Proc. Natl. Acad. Sci. 98: 8966-8971, 2001.
Bunzow, J.R., et al., “Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters are Agonists of a Rat Trace Amine Receptor”,Mol. Pharmacol.60: 1181-1188, 2001.
Buu-Hoi, N.P. et al., “Some Biological Effects of Thyronamine”,Med. Pharmacol. exp. 15: 17-23, 1966.
Buu-Hoi, N.P., et al., “Thyronamine, a New Substance with Long-acting positive Inotropic Effect”,Pharmacology2: 281-287, 1969.
Cody et al., “Molecular Structure and Biochemical Activity of 3,5,3′- Triiodothyronamine”,Endocrine Research, 10: 91-99, 1984.
Cote, P., et al., “Thyronamine, a new inotropic agent: its cardiovascular effects and mechanism of action”,Cardiovascular Res. 8: 721-730, 1974.
Dratman, M., “On the Mechanism if Action of Thyroxin, an Amino Acid Analog of Tyrosine”,J. theor. Biol., 46: 255-270, 1974.
Falkenstein, E., et al., “Multiple Actions of Steroid Hormones-A Focus on Rapid, Nongenomic Effects”,Pharmacol. Rev. 52: 513-555, 2000.
Hamilton, M.A., et al., “Safety and Hemodynamic Effects of Intravenous Triiodothyronine in Advanced Congestive Heart Failure”,Am. J. Cardiol. 81: 443-447, 1998.
Han, et al., “Synthesis of side chain-modified idothyronines”,Int. J. Peptide Protein Res., 30: 652-661, 1987.
Meyer, T., et al., “Triiodothyronamine- A Beta-adrenergic Metabolite of Triiodothyronine?”,Horm. metabol. Res. 15: 602-606, 1983.
Petit, L. et al., “A Synthesis of Thyronamine and Its Lower Homolog”,J. org. Chem. 26: 3832-4, 1961.
Rozanov, C.B., et al., “Immunohistochemical Mapping of Brain Triiodothyronine Reveals Prominent Localization in Central Noradrenergic Systems”,Neuroscience, 74: 897-915, 1996.
Stöhr, R., “Synthese des Thyronamins”,Hoppe-Seyler Z. physiol. Chem. 201: 142-149, 1931.
Sun, Z.-Q., et al., “Effects of thyroid hormone on action potential and repolarizing currents in rat ventricular myocytes”,Am. J. Physiol. Endocrinol. Metab. 278: E302-E307, 2000.
Thibault, O., “Recherhes sur la nature de la <<thyroxine active>> . Renforcement immediate par la thyroxamine des effets de l'adrénaline sur divers muscles lisses”,1951C. R. Soc. Chim. biol., 797-800.
Tomita, K., et al., “Synthesis and Biological Activity of Some Triiodinated Analogues of Thyroxine”,J. Biol. Chem.219: 595-604, 1956.
Walker, J.D., et al., “The novel effects of 3,5,3′-triiodo-L-thyronine on myocyte contractile function and β-adrenergic responsivness in dilated cardiomyopathy”,J. Thorac. Cardiovasc. Surg. 108: 672-679, 1994.
Yen, P.M., “Physiological and Molecular Basis of Thyroid Hormone Action”,Physiol. Rev. 81: 1097-1142, 2001.
Database CAPLUS on STN, Acc. No. 1971:135556, Fuller et al., J Medicinal Chemistry (1971), 14(4), p. 322-5 (abstract).
N.F. Buu-Hoi et al., “Synthesis and Pharmacological Properties of 3,5-Diiodothyronamine,” 1969,Chimica Therapeutica, 4(3), 151-156. abstract, 1 page.
Barnes, J.H. et al., “Synthesis of throxine and related substances, XII, Preparation of simple analogs of thyroxine,”Journal of the Chemical Society, 1953, Database CA [online], Accession No. 1954:24942, abstract, 1 page.
Barton, D.H.R. et al., “The biosynthesis of Amaryllidaceae alkaloids,”Proc. Chem. Soc., 1961, Database CA [online], Accession No. 1961:137639, abstract, 1 page.
Bhakuni, D.S. et al., “Synthesis of (.+-.)-scoulerine, (.+-.)-coreximine, (-+-.)-tetrahydropalmatine and their monobromo and dibromo derivatives,”Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry,1983, Database CA [online], Accession No. 1983:488435, 22B(1), abstract, 1 page.
Bompart, Jaques et al., “Synthesis of new .beta.-blocking analogs of bevantolol,”Annales oPharmaceutiques Francaises, 1985, Database CA [online], Accession No. 1985:215069 42(5), abstract, 1 page.
Chen, Chi-Ming et al., “Synthesis of (.+-.)-annonelliptine and (.+-.)-anomoline,”Journal of Natural Products, 1995, Database CA [online], Accession No. 1996:52130, 58(11), abstract, 1 page.
Davis, Bruce, “crown ether-catalyzed deuterium exhange in the synthesis of benzyl cyanides,”Journal of Labelled Compounds and Radiopharmaceuticals, 1987, Database CA [online], Accession No. 1987:575570, 24(2), abstract, 1 page.
Funke, A. et al., “Preparation of several series of amine derivatives of diphenyl ethers,”Bulletin de la Societe Chimique de France, 1951, Database [online], Accession No. 1953:25301, abstract, 1 page.
Horvath, Dragos, “A Virtual Screening Approach Applied to the Search for Trypanothione Reductase Inhibitors,”J. Med. Chem., 1997, 40, 2412-2423.
Il'yuchenok, I. Yu. et al., “Radioprotective and pharmacological properties of some phenylethylamine derivatives,” 1976, Database CA [online], Accession No. 1977:218, 39(5), abstract, 1 page.
Kametani, Tetsuji et al., “Syntheses of heterocyclic compounds, CCCLXXXVI, Alternative total syntheses of galanthamine and N-benzylgalanthamine iodide,”Journal of the Chemical Society, 1971, Database CA [online], Accession No. 1971:406156, 6, abstract, 1 page.
Kametani, Tetsuji et al., “Studies on the Syntheses of heterocyclic compounds. CCCXV. Modified total synthesis of (=)-galanthamine through phenol oxidation,”Journal of the Chemical Society, 1969, Database CA [online], Accession No. 1970:21811, section C (18), abstract, 1 page.
Kim, Jin Mi et al., “Preparation of 4-amino-1-benzylpiperidines as antimalarials,”WO 01/14331Regents of University of California, 2001, Database CA [online], Accession No. 2001:152643, abstract, 2 pages.
Kukovinets, O.S. et al., “Synthesis of fenoxycarb, a highly active juvenoid and its analog,”Bashikirskii Khimicheskii Zhurnal, 1995, Database CA [online], Accession No. 1996:246214, 2(1), abstract, 1 page.
Lu, Rong Jian et al., “Detritylation with ytterbium triflate,”Tetrahedron Letters, 2000, Database CA [online], Accession No. 2000:303504, 41(16), abstract, 1 page.
Slotta, K.H. et al., “Synthesis of thyroxine-like substances from diphenyl ether,”Berichte der Deutschen Chemischen Gesellschaft[Abteilung]B: Abhandlungen, 1936, Database CA [online], Accession No. 1936:34165, 65(B), abstract, 1 page.
Suzuki, Toshikazu et al., “Metabolism of a new cardiotonic agent, (-)-.alpha.-(3,4-dimethoxyphenethylaminomethyl)-4-hydroxybe nzyl alcohol (TA-064), in man. O-Dimethylation and ring hydroxylation,”Drug Metabolism and Disposition,1983, Database CA [online], Accession No. 1983:515496, 11(4), abstract, 1 page.
Nillne, E.A. et al., “Deficiencies in Pro-thyrotropin-releasing Hormone Processing and Abnormalities in Thermoregulation inCpefat/fatMice,”J. Biol. Chem.,2002, 277(50), 48587-48595.
Ribeiro, M.O. et al., “Thyroi
Bunzow James R.
Grandy David K.
Hart Matthew E.
Scanlan Thomas S.
Davis Brian
Oregon Health & Science University
Woodcock & Washburn LLP
LandOfFree
Thyronamine derivatives and analogs and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thyronamine derivatives and analogs and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thyronamine derivatives and analogs and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3928554